Jaymun's Journey Birth Facts Family Photos Jaymun's Journal Blog Medical Information Jaymun's Guestbook Videos of Jaymun
Jaymun's Journey
Psalm 44:3
Visitor: visitors since 11/6/06
Copyright (c) 2006-2008     Dave and Jennifer Kaat
All Rights Reserved
Mailing Address

Infant Nutrition



Jaymun was breastfed for the first 13 weeks of his life. The antibodies in his mothers milk protected him from things like CMV. It was very traumatic to stop breastfeeding during his third chemo round (pre-transplant). Our original plan was to have him breastfed at least up to the beginning of transplant conditioning - but we were advised otherwise.
Unfortunately, weaning him backfired - because without his mother's antibodies to protect him, he later contracted CMV from the environment.

The doctors made a tough decision that we deferred to at the time. However, given our later experience, I tend to agree with our original plan. In order to be convinced otherwise, they would have to show that:

the % risk of the mother expressing the CMV in her milk,
lowered by the % risk of the child contracting the disease even if it was expressed,
lowered yet again by the % protection the mothers natural antibodies provide,

was nevertheless a larger risk
...than the child contracting the disease from an environment already proven to be CMV positive (80% of us are).

And even if those risks were equal, that still doesn't even begin to take into consideration the overwhelming body of evidence of other large risks incurred (benefits lost) by early weaning of a child. Although, to be fair, since we were planning a bone marrow transplant, I am not sure how many of those other protections would be kept.

Yet, our own experience with Jaymun backs up my own feelings - my own "comparative risk analysis".
Remember - the closest we came to losing Jaymun up till now was Dec 12/13 - and a good part of the medical "source" of that traumatic crisis is because we weaned him, increasing his risk for CMV (in my opinion :).

Human Breast Milk Advantages:

Development
Development [Human milk oligosaccharides. The rule in the health and development of the infants]

Disease protection
Disease Protection (Human milk glycans protect infants against enteric pathogens).
Diarrhea Reduction (Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants.)

Effect on Transplants (Renal for example):
Maternal Transplant Success (Breast feeding and maternal-donor renal allografts) (25% improvement)
Sibling Transplant Success (Influence of breast feeding on subsequent reactivity to a related renal allograft.)

Effects on "Immunologically Challenged" patients
Sepsis Reduction (Human Milk Feedings and Infection Among Very Low Birth Weight Infants )

Decreased Cancer Risks (during chemo there is a big risk of secondary cancers)
Breast feeding and childhood hematological malignancy
-21% Leukemia Risk (http://jnci.oxfordjournals.org/cgi/content/abstract/91/20/1765)

Hundreds of other studies
Breastmilk Studies Organized


Med Summary

Med Data:
  BM-RPIC -6/6
  Labs -7/7
  H Labs -7/11
  C Labs -7/11
  H Labs -7/16
  C Labs -7/16
  Head CT 7/18
  H Labs -7/21
  C Labs -7/21
  Head CT -7/21
  H Labs -7/26
  C Labs -7/26
  Head CT -7/28
  H Labs -8/04
  C Labs -8/04
  Head CT -8/04
  H Labs -8/18
  C Labs -8/18
  H Labs -9/04
  C Labs -9/04
  VNTR -9/04

Supplements:
  Purpose/Goals
  Methods
  Dosage Log
    Feverfew
    Tumeric
    Rieshi Mush.
    Una da Gato
    Onions
    Apples
    Green Tea
    Astragalus
    Milk Thistle
    Synbiotics
    Vitamin K2
    Vitamin E
    Fish Oil
    Parsley
    Burdock
    Echinacea
    Garlic
    Mangosteen
    Pau d'Arco

Work in Progress:
    Aloe Vera
    Soy
    Mistletoe
    Boswellia
    Vitamin D3
    Honokiol
    Pomegranate
    Goji
    Thunder Of God
    Others

Relapse Ramblings

Acute Myeloid
Leukemia


Infant Nutrition

Alternative
Therapy?